ETHK Labs (HKSE:01931) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01931 ETHK Labs Inc HKSE:01931
74 GF Score
Price HK$0.58
GF Value HK$1.38
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is ETHK Labs FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:01931
74GF Score
ETHK Labs Inc HKSE:01931
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ETHK Labs (HKSE:01931) Overvalued in 2026?

Based on GuruFocus' analysis, ETHK Labs stock appears to be undervalued. The current stock price of HK$0.58 is trading 58% below its estimated GF Value™ of HK$1.38. GuruFocus considers ETHK Labs to be Possible Value Trap.

Key valuation signals for HKSE:01931:

  • FFO:
  • GF Value™: HK$1.38 vs. price of HK$0.58 (58% below fair value)
  • GF Score™: 74/100 with 9 warning signs

No single metric tells the full story. See the HKSE:01931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ETHK Labs Business Description

Address Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
74GF Score

Get the complete analysis for HKSE:01931

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.58
Price
HK$1.38
GF Value